In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a cyclohexa-1,3,5-triene-1,3,5-triol Drug Master File in Korea (cyclohexa-1,3,5-triene-1,3,5-triol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of cyclohexa-1,3,5-triene-1,3,5-triol. The MFDS reviews the cyclohexa-1,3,5-triene-1,3,5-triol KDMF as part of the drug registration process and uses the information provided in the cyclohexa-1,3,5-triene-1,3,5-triol KDMF to evaluate the safety and efficacy of the drug.
After submitting a cyclohexa-1,3,5-triene-1,3,5-triol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their cyclohexa-1,3,5-triene-1,3,5-triol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of cyclohexa-1,3,5-triene-1,3,5-triol suppliers with KDMF on PharmaCompass.